Immune checkpoint inhibitor myocarditis: a metagenomic investigation of infectious pathogens

This publication has 10 references indexed in Scilit:

• Shotgun metagenomics for the diagnosis of infections: A prospective study
  Journal of Infection, 2025
• 2025 ESC Guidelines for the management of myocarditis and pericarditis
  European Heart Journal, 2025
• Immune checkpoint inhibitor-associated myocarditis: a novel risk score
  European Heart Journal, 2025
• Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade—a worldwide perspective
  eClinicalMedicine, 2024
• Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
  Nature Medicine, 2023
• Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis
  Circulation, 2023
• Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis
  Cancer Discovery, 2023
• A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis
  Nature Medicine, 2019
• Abatacept for Severe Immune Checkpoint Inhibitor–Associated Myocarditis
  New England Journal of Medicine, 2019
• Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
  The Lancet Oncology, 2018